Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01933048 · ClinicalTrials.gov registry record · Phase 4
Self-Administered Nasal Influenza Feasibility Study
A Phase 4 study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,077
- Enrollment target
NCT01933048: Completed Phase 4 study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
NCT01933048 is a Phase 4 study that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 1,077 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (108% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01933048, a Phase 4 study, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,077 participants
- Enrollment target
Study Summary
The purpose of this prospective, open-label clinical trial is to evaluate the immunogenicity of self-administered (SA) live, attenuated influenza vaccine (LAIV) in comparison with healthcare worker administered (HCWA) LAIV and to evaluate the feasibility of group self-administration of LAIV.
Interventions
- DRUG FluMist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,077 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
What the finished NCT01933048 record still lists
NCT01933048 is an interventional study that assigns participants to a tested intervention. Its 1,077 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (108% higher).
The record links to 0 conditions, and to 1 intervention - of which FluMist is the first listed.
NCT01933048 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01933048 about?
NCT01933048 is a clinical study titled "Self-Administered Nasal Influenza Feasibility Study". The purpose of this prospective, open-label clinical trial is to evaluate the immunogenicity of self-administered (SA) live, attenuated influenza vaccine (LAIV) in comparison with healthcare worker administered (HCWA) LAIV and to evaluate the feasibility of group self-administration of LAIV.
What is the current status of trial NCT01933048?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,077 participants. The study started on 2012-09. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01933048?
The interventions under investigation include: FluMist (DRUG).
Who is sponsoring clinical trial NCT01933048?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01933048's enrollment target sits among peer trials
1,077 66th of 2000 higher than 1,935 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
- NCT07213804 · 1,080 participants · Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia